Key Drivers
- High ROE
- High leverage
- Tight liquidity
AIAI Summary
PACS is no longer a pure organic post-acute story but a leverage-driven roll-up where investment returns now hinge as much on rapid integration and deleveraging (quarterly cash conversion, working-capital normalization, and refinance timing) as on facility performance—monitor q/q FCF, D/E trajectory and upcoming maturities as the primary value inflection points. The biggest actionable risk is refinancing/liquidity pressure: failure to sustain positive quarterly cash flow or refinance on favorable terms would quickly compress multiples and equity value despite operational improvements.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High ROE
- •High leverage
- •Tight liquidity
PACS delivers strong ROE (~20%) and positive full‑year free cash flow but is hampered by high leverage, tight liquidity and volatile quarterly cash flow while trading at rich multiples.
Price Behavior
Key Price Behavior Insights:
- •Downside momentum
- •Elevated volatility
- •Resistance 37–42
PACS has shown clear negative momentum over the last month with a ~13–14% drop, a sharp peak‑to‑trough decline from late Feb into mid‑March, support near the recent low (around 2026-03-20) and resistance at $37–$42 where rebounds may stall.
Sharp peak-to-trough drop from late
Sentiment & News
Key News Insights:
- •Strong revenue
- •Q4 EPS miss
- •Analyst optimism
PACS Group delivered strong FY‑2025 revenue and profitability but missed Q4 EPS, prompting a technical sell‑off even as analysts remain constructive and strategic catalysts loom.
Solid fundamentals support upside potential, but near‑term stock volatility is likely until earnings execution and technical support improve
Similar Companies in Financial Services
Other companies in the same sector with AI ratings